Literature DB >> 17368674

Long-term prognosis of multiple sclerosis in Australia.

J G McLeod1, M H Barnett, P Macaskill, D B Williams.   

Abstract

Long-term survival and progression of disability in multiple sclerosis have not been studied previously in Australia. We report the findings in a cohort of 159 patients from Newcastle. Median survival time from onset of symptoms to death was 42 years. When expected survival rates are compared with those of the Australian population, there is approximately a 10% reduction in survival time in multiple sclerosis patients, after 20 years or more from disease onset. The expected time to reach DSS 3 and DSS 6 was 7 years and 27 years respectively. Survival time of multiple sclerosis patients and rate of progression of the disease are similar in the Northern and Southern Hemispheres.

Entities:  

Mesh:

Year:  2007        PMID: 17368674     DOI: 10.1016/j.jns.2007.02.004

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Predictors of Mortality in Veterans with Multiple Sclerosis in an Outpatient Clinic Setting.

Authors:  Meheroz H Rabadi; Christopher E Aston
Journal:  Int J MS Care       Date:  2017 Sep-Oct

2.  Estimating typical multiple sclerosis disability progression speed from clinical observations.

Authors:  Murray G Brown; Mark Asbridge; Vern Hicks; Sarah Kirby; Thomas J Murray; Pantelis Andreou; Dong Lin
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.